Doliver Advisors, LP Abb Vie Inc. Transaction History

Doliver Advisors, LP

  • $346 Million
  • Q3 2024

A detailed history of Doliver Advisors, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Doliver Advisors, LP holds 5,217 shares of ABBV stock, worth $868,995. This represents 0.3% of its overall portfolio holdings.

Number of Shares
5,217
Previous 6,166 15.39%
Holding current value
$868,995
Previous $1.06 Million 2.55%
% of portfolio
0.3%
Previous 0.3%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024
SELL
$163.84 - $199.33 $155,484 - $189,164
-949 Reduced 15.39%
5,217 $1.03 Million
Q2 2024

Jul 12, 2024
BUY
$154.79 - $180.76 $309 - $361
2 Added 0.03%
6,166 $1.06 Million
Q1 2024

Apr 12, 2024
SELL
$159.82 - $182.1 $1,278 - $1,456
-8 Reduced 0.13%
6,164 $1.12 Million
Q4 2023

Jan 03, 2024
BUY
$137.6 - $154.97 $275 - $309
2 Added 0.03%
6,172 $956,000
Q3 2023

Oct 10, 2023
SELL
$133.59 - $154.65 $62,520 - $72,376
-468 Reduced 7.05%
6,170 $919,000
Q2 2023

Aug 07, 2023
SELL
$132.51 - $164.9 $15,636 - $19,458
-118 Reduced 1.75%
6,638 $894,000
Q1 2023

May 12, 2023
BUY
$144.61 - $166.54 $289 - $333
2 Added 0.03%
6,756 $1.08 Million
Q4 2022

Feb 07, 2023
BUY
$138.31 - $165.87 $138 - $165
1 Added 0.01%
6,754 $1.09 Million
Q3 2022

Nov 09, 2022
SELL
$134.21 - $153.93 $67,507 - $77,426
-503 Reduced 6.93%
6,753 $906,000
Q2 2022

Aug 15, 2022
SELL
$137.62 - $174.96 $246,202 - $313,003
-1,789 Reduced 19.78%
7,256 $1.11 Million
Q1 2022

May 09, 2022
SELL
$131.98 - $163.75 $697,382 - $865,255
-5,284 Reduced 36.88%
9,045 $1.47 Million
Q4 2021

Feb 07, 2022
SELL
$107.43 - $135.93 $342,271 - $433,072
-3,186 Reduced 18.19%
14,329 $2.02 Million
Q3 2021

Nov 03, 2021
BUY
$106.4 - $120.78 $141,724 - $160,878
1,332 Added 8.23%
17,515 $1.89 Million
Q2 2021

Aug 06, 2021
BUY
$105.21 - $117.21 $76,066 - $84,742
723 Added 4.68%
16,183 $1.82 Million
Q1 2021

May 07, 2021
BUY
$102.3 - $112.62 $114,985 - $126,584
1,124 Added 7.84%
15,460 $1.67 Million
Q4 2020

Feb 04, 2021
BUY
$80.49 - $108.67 $82,743 - $111,712
1,028 Added 7.72%
14,336 $1.54 Million
Q3 2020

Nov 13, 2020
BUY
$85.91 - $100.83 $39,518 - $46,381
460 Added 3.58%
13,308 $1.17 Million
Q2 2020

Aug 10, 2020
BUY
$73.37 - $98.18 $13,866 - $18,556
189 Added 1.49%
12,848 $1.26 Million
Q1 2020

Apr 28, 2020
SELL
$64.5 - $97.79 $92,364 - $140,035
-1,432 Reduced 10.16%
12,659 $1.07 Million
Q4 2019

Jan 27, 2020
SELL
$72.13 - $90.25 $6,203 - $7,761
-86 Reduced 0.61%
14,091 $1.25 Million
Q3 2019

Nov 04, 2019
BUY
$62.98 - $75.72 $47,297 - $56,865
751 Added 5.59%
14,177 $1.06 Million
Q2 2019

Jul 25, 2019
BUY
$65.7 - $83.98 $12,483 - $15,956
190 Added 1.44%
13,426 $976,000
Q1 2019

May 13, 2019
BUY
$77.14 - $90.79 $44,046 - $51,841
571 Added 4.51%
13,236 $1.07 Million
Q4 2018

Jan 31, 2019
SELL
$77.85 - $96.01 $23,121 - $28,514
-297 Reduced 2.29%
12,665 $1.17 Million
Q3 2018

Nov 02, 2018
BUY
$88.91 - $98.84 $101,713 - $113,072
1,144 Added 9.68%
12,962 $1.23 Million
Q2 2018

Aug 14, 2018
BUY
$89.78 - $106.23 $38,695 - $45,785
431 Added 3.79%
11,818 $1.1 Million
Q1 2018

May 08, 2018
SELL
$92.01 - $123.21 $55,113 - $73,802
-599 Reduced 5.0%
11,387 $0
Q4 2017

Feb 12, 2018
SELL
$89.56 - $98.21 $92,246 - $101,156
-1,030 Reduced 7.91%
11,986 $1.16 Million
Q3 2017

Nov 03, 2017
BUY
$69.85 - $89.22 $909,167 - $1.16 Million
13,016
13,016 $1.16 Million

Others Institutions Holding ABBV

# of Institutions
3,846
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $295B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Doliver Advisors, LP Portfolio

Follow Doliver Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Doliver Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email